Jefferies Boosts Price Target On ViroPharma (VPHM) Following Q4

February 29, 2012 9:14 AM UTC
Get Alerts VPHM Hot Sheet
Price: $49.96 --0%

Rating Summary:
    5 Buy, 9 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Jefferies raised its price target on ViroPharma (NASDAQ: VPHM) from $32 to $37 following Q4 results.

The firm comments, "VPHM reported 4Q11 earnings and reiterated previously issued 2012 guidance. Focus remains on Cinryze as VPHM expands manufacturing capacity and considers new potential indications, such as PNH and AIHA. We remain confident that VPHM will address FDA manufacturing concerns in a timely manner and remain long-term buyers."

Jefferies raised Q1 EPS from $0.47 to $0.48, FY12 trimmed from $2.08 to $2.04 and FY13 up form $2.61 to $2.72.


For an analyst ratings summary and ratings history on ViroPharma click here. For more ratings news on ViroPharma click here.

Shares of ViroPharma closed at $32.24 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co, Earnings